Skip to content

daVinci Digital Therapeutics

  • Home
  • DTx Blog
  • DTx Newsletter
  • News
  • Pipeline
  • Events
  • DTxDay20
  • Contact us
  • Home
  • DTx Blog
  • DTx Newsletter
  • News
  • Pipeline
  • Events
  • DTxDay20
  • Contact us

daVinci Digital Therapeutics

a Digital Biotech Company

Monthly Archive: February 2021

Digital Health

6 February 2021

 by daVinciDTx · Published 6 February 2021

White paper reveals pathway for digital therapeutics use in Italy

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics,...

Recent Posts

  • White paper reveals pathway for digital therapeutics use in Italy
  • Digital Therapeutics, an Opportunity for Italy
  • Digital Therapeutics Day 2020 – Where Are We Now? We Are We Going?
  • Startup – Corporate collaboration to develop DTx
  • What are DTx Digital Excipients?
  • The New Era of Programmable Medicines
  • Programmable Medicines and Digital Biotechnology
  • Digital Therapeutics – What They Are, What They Will Be
  • Digital Therapeutic to Treat Adjustment Disorders during COVID-19
  • FDA has approved Somryst, a Digital Therapeutic to treat chronic insomnia
  • Research & Development of Digital Therapeutics

daVinci Digital Therapeutics
Via Giovanni Durando 38
20158 Milan – I
+ 39 02 2399 2985
https://davincidtx.com

Digital Therapeutics Day 2020 #DTxDAY20

https://www.youtube.com/watch?v=LVLd8gkuZuo&list=PLZQ1y6mMVircvV7EwcK4vLLHM0vW9r6Br&index=1&t=45s

ARCHIVES

  • February 2021
  • January 2021
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020

CATEGORIES

  • COVID-19
  • Digital Health
  • R&D
  • Research

Partnerships

Privacy Policy

Code of Ethics

daVinci Digital Therapeutics srl, Milan 2020